[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Lu, K.H. and Broaddus, R.R. (2020) Endometrial Cancer. The New England Journal of Medicine, 383, 2053-2064. https://doi.org/10.1056/NEJMra1514010
|
[3]
|
Oaknin, A., Bosse, T.J., Creutzberg, C.L., et al. (2022) Endometrial Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 33, 860-877. https://doi.org/10.1016/j.annonc.2022.05.009
|
[4]
|
Abu-Rustum, N.R., Yashar, C.M., Bradley, K., et al. (2021) NCCN Guidelines® Insights: Uterine Neoplasms, Version 3. Journal of the National Comprehensive Cancer Network: JNCCN, 19, 888-895. https://doi.org/10.6004/jnccn.2021.0038
|
[5]
|
Gu, Y., Cheng, H., Zong, L., et al. (2020) Operative and Oncological Outcomes Comparing Sentinel Node Mapping and Systematic Lymphadenectomy in Endometrial Cancer Staging: Meta-Analysis with Trial Sequential Analysis. Frontiers in Oncology, 10, Article ID: 580128. https://doi.org/10.3389/fonc.2020.580128
|
[6]
|
Pölcher, M., Rottmann, M., Brugger, S., et al. (2019) Lymph Node Dissection in Endometrial Cancer and Clinical Outcome: A Population-Based Study in 5546 Patients. Gynecologic Oncology, 154, 65-71. https://doi.org/10.1016/j.ygyno.2019.04.002
|
[7]
|
Zorzato, P.C., Bosco, M., Franchi, M.P., et al. (2021) Sentinel Lymph Node for Endometrial Cancer Treatment: Review of the Literature. Minerva Medica, 112, 70-80. https://doi.org/10.23736/S0026-4806.20.07117-7
|
[8]
|
Geppert, B., Lönnerfors, C., Bollino, M., et al. (2018) Sentinel Lymph Node Biopsy in Endometrial Cancer-Feasibility, Safety and Lymphatic Complications. Gynecologic Oncology, 148, 491-498. https://doi.org/10.1016/j.ygyno.2017.12.017
|
[9]
|
Liu, C.Y., Elias, K.M., Howitt, B.E., et al. (2017) Sentinel Lymph Node Mapping Reduces Practice Pattern Variations in Surgical Staging for Endometrial Adenocarcinoma: A before and after Study. Gynecologic Oncology, 145, 248-255. https://doi.org/10.1016/j.ygyno.2017.03.012
|
[10]
|
Matsuo, K., Klar, M., Khetan, V.U., et al. (2022) Sentinel Lymph Node Biopsy for Stage II Endometrial Cancer: Recent Utilization and Outcome in the United States. Gynecologic Oncology, 164, 46-52. https://doi.org/10.1016/j.ygyno.2021.10.085
|
[11]
|
Glaser, G., Dinoi, G., Multinu, F., et al. (2021) Reduced Lymphedema after Sentinel Lymph Node Biopsy versus Lymphadenectomy for Endometrial Cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 31, 85-91. https://doi.org/10.1136/ijgc-2020-001924
|
[12]
|
Zhai, L., Zhang, X., Cui, M., et al. (2021) Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review. Frontiers in Oncology, 11, Article ID: 701758. https://doi.org/10.3389/fonc.2021.701758
|
[13]
|
Marchocki, Z., Cusimano, M.C. and Ferguson, S.E. (2022) Sentinel Lymph Node Biopsy in High-Grade Endometrial Cancer. American Journal of Obstetrics and Gynecology, 226, 867-868. https://doi.org/10.1016/j.ajog.2022.02.013
|
[14]
|
Marchocki, Z., Cusimano, M.., Clarfield, L., et al. (2021) Sentinel Lymph Node Biopsy in High-Grade Endometrial Cancer: A Systematic Review and Meta-Analysis of Performance Characteristics. American Journal of Obstetrics and Gynecology, 225, 367.e1-367.e39.
|
[15]
|
Ye, L., Li, S., Lu, W., et al. (2019) A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes? The Oncologist, 24, E1381-E1387. https://doi.org/10.1634/theoncologist.2019-0113
|
[16]
|
Nagar, H., Wietek, N., Goodall, R.J., et al. (2021) Sentinel Node Biopsy for Diagnosis of Lymph Node Involvement in Endometrial Cancer. Cochrane Database of Systematic Reviews, 6, CD013021. https://doi.org/10.1002/14651858.CD013021.pub2
|
[17]
|
Zuo, J., Wu, L.Y., Cheng, M., et al. (2019) Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification. Journal of Minimally Invasive Gynecology, 26, 1125-1132. https://doi.org/10.1016/j.jmig.2018.11.002
|
[18]
|
Backes, F.J., Cohen, D., Salani, R., et al. (2019) Prospective Clinical Trial of Robotic Sentinel Lymph Node Assessment with Isosulfane Blue (ISB) and Indocyanine Green (ICG) in Endometrial Cancer and the Impact of Ultrastaging (NCT01818739). Gynecologic Oncology, 153, 496-499. https://doi.org/10.1016/j.ygyno.2019.03.252
|
[19]
|
Cabrera, S., Barahona-Orpinell, M., Almansa-González, C., et al. (2021) Combined Use of ICG and Technetium Does Not Improve Sentinel Lymph Node Detection in Endometrial Cancer: Results of the COMBITEC Study. Gynecologic Oncology, 162, 32-37. https://doi.org/10.1016/j.ygyno.2021.05.002
|
[20]
|
Cusimano, M.C., Vicus, D., Pulman, K., et al. (2021) Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate-and High-Grade Endometrial Cancer Staging. JAMA Surgery, 156, 157-164. https://doi.org/10.1001/jamasurg.2020.5060
|
[21]
|
Maramai, M., Achilarre, M.T., Aloisi, A., et al. (2021) Cervical Re-Injection of Indocyanine Green to Improve Sentinel Lymph Node Detection in Endometrial Cancer. Gynecologic Oncology, 162, 38-42. https://doi.org/10.1016/j.ygyno.2021.04.026
|
[22]
|
Farazestanian, M., Yousefi, Z., Zarifmahmoudi, L., et al. (2019) Concordance between Intracervical and Fundal Injections for Sentinel Node Mapping in Patients with Endometrial Cancer? A Study Using Intracervical Radiotracer and Fundal Blue Dye Injections. Clinical Nuclear Medicine, 44, E123-E127. https://doi.org/10.1097/RLU.0000000000002412
|
[23]
|
Ditto, A., Casarin, I., Pinelli, C., et al. (2020) Hysteroscopic versus Cervical Injection for Sentinel Node Detection in Endometrial Cancer: A Multicenter Prospective Randomised Controlled Trial from the Multicenter Italian Trials in Ovarian Cancer (MITO) Study Group. European Journal of Cancer (Oxford, England: 1990), 140, 1-10. https://doi.org/10.1016/j.ejca.2020.08.030
|
[24]
|
Persson, J., Geppert, B., Lönnerfors, C., et al. (2017) Description of a Reproducible Anatomically Based Surgical Algorithm for Detection of Pelvic Sentinel Lymph Nodes in Endometrial Cancer. Gynecologic Oncology, 147, 120-125. https://doi.org/10.1016/j.ygyno.2017.07.131
|
[25]
|
Persson, J., Salehi, S., Bollino, M., et al. (2019) Pelvic Sentinel Lymph Node Detection in High-Risk Endometrial Cancer (SHREC-Trial)—The Final Step towards a Paradigm Shift in Surgical Staging. European Journal of Cancer (Oxford, England: 1990), 116, 77-85. https://doi.org/10.1016/j.ejca.2019.04.025
|
[26]
|
García Pineda, V., Hernández Gutiérrez, A., Gracia Segovia, M., et al. (2020) Low-Volume Nodal Metastasis in Endometrial Cancer: Risk Factors and Prognostic Significance. Journal of Clinical Medicine, 9, Article No. 1999. https://doi.org/10.3390/jcm9061999
|
[27]
|
Ghoniem, K., Larish, A.M., Dinoi, G., et al. (2021) Oncologic Outcomes of Endometrial Cancer in Patients with Low-Volume Metastasis in the Sentinel Lymph Nodes: An International Multi-Institutional Study. Gynecologic Oncology, 162, 590-598. https://doi.org/10.1016/j.ygyno.2021.06.031
|
[28]
|
Backes, F.J., Felix, A.S., Plante, M., et al. (2021) Sentinel Lymph Node (SLN) Isolated Tumor Cells (ITCs) in Otherwise Stage I/II Endometrioid Endometrial Cancer: to Treat or Not to Treat? Gynecologic Oncology, 161, 347-352. https://doi.org/10.1016/j.ygyno.2021.02.017
|
[29]
|
Concin, N., Matias-Guiu, X., Vergote, I., et al. (2021) ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial Carcinoma. Radiotherapy and Oncology, 154, 327-353. https://doi.org/10.1016/j.radonc.2020.11.018
|
[30]
|
Sims, T.T. and Boruta, D.M. (2021) Sentinel Lymph Node Isolated Tumor Cells in Early Staged Endometrioid Endometrial Cancer: Utility or Futility? Gynecologic Oncology, 161, 331-332. https://doi.org/10.1016/j.ygyno.2021.04.006
|
[31]
|
Goebel, E.A., St Laurent, J.D., Nucci, M.R., et al. (2020) Retrospective Detection of Isolated Tumor Cells by Immunohistochemistry in Sentinel Lymph Node Biopsy Performed for Endometrial Carcinoma: Is There Clinical Significance? International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 30, 291-298. https://doi.org/10.1136/ijgc-2019-000934
|
[32]
|
Bogani, G., Mariani, A., Paolini, B., et al. (2019) Low-Volume Disease in Endometrial Cancer: The Role of Micrometastasis and Isolated Tumor Cells. Gynecologic Oncology, 153, 670-675. https://doi.org/10.1016/j.ygyno.2019.02.027
|
[33]
|
Diestro, M.D., Berjón, A., Zapardiel, I., et al. (2021) One-Step Nucleic Acid Amplification (OSNA) of Sentinel Lymph Node in Early-Stage Endometrial Cancer: Spanish Multicenter Study (ENDO-OSNA). Cancers, 13, Article No. 4465. https://doi.org/10.3390/cancers13174465
|
[34]
|
Kosťun, J., Pešta, M., Sláma, J., et al. (2019) One-Step Nucleic Acid Amplification vs Ultrastaging in the Detection of Sentinel Lymph Node Metastasis in Endometrial Cancer Patients. Journal of Surgical Oncology, 119, 361-369. https://doi.org/10.1002/jso.25322
|
[35]
|
Togami, S., Ushiwaka, T., Kitazono, I., et al. (2022) One-Step Nucleic Acid Amplification (OSNA) Assay for Detecting Lymph Node Metastasis in Cervical and Endometrial Cancer: A Preliminary Study. Journal of Gynecologic Oncology, 33, E11. https://doi.org/10.3802/jgo.2022.33.e11
|
[36]
|
Angeles, M.A., Martínez-Gómez, C., Migliorelli, F., et al. (2018) Novel Surgical Strategies in the Treatment of Gynecological Malignancies. Current Treatment Options in Oncology, 19, Article No. 73. https://doi.org/10.1007/s11864-018-0582-5
|
[37]
|
Pineda, V.G., Zapardiel, I., Gracia, M., et al. (2021) Avoiding Full Lymphadenectomies in Intermediate-and High-Risk Endometrial Cancer by Sentinel Lymph Node Biopsy Implementation. Frontiers in Oncology, 11, Article ID: 654285. https://doi.org/10.3389/fonc.2021.654285
|
[38]
|
Pijnenborg, J.M.A., Reijnen, C., Vergeldt, T.F.M., et al. (2020) Optimizing the Treatment Algorithm for Sentinel Lymph Node Mapping in Endometrial Cancer. Seminars in Oncology, 47, 138-143. https://doi.org/10.1053/j.seminoncol.2020.04.006
|
[39]
|
Kogan, L., Matanes, E., Wissing, M., et al. (2020) The Added Value of Sentinel Node Mapping in Endometrial Cancer. Gynecologic Oncology, 158, 84-91. https://doi.org/10.1016/j.ygyno.2020.04.687
|
[40]
|
Torrent, A., Amengual, J., Sampol, C.M., et al. (2022) Sentinel Lymph Node Biopsy in Endometrial Cancer: Dual Injection, Dual Tracer—A Multidisciplinary Exhaustive Approach to Nodal Staging. Cancers, 14, Article No. 929. https://doi.org/10.3390/cancers14040929
|